secwatch.observer — SEC 8-K summary
======================================

Issuer:     IRONWOOD PHARMACEUTICALS INC (IRWD)
CIK:        0001446847
Form:       8-K
Filed at:   2024-12-05T23:59:59+00:00
Accession:  0001104659-24-125937
Event type: leadership
Sentiment:  negative
Materiality: 0.65
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Ironwood CFO Sravan Emany resigns effective Dec 18; CEO McCourt interim PFO
---------------------------------------------------------------------------

- Sravan Emany resigns as SVP, COO, and CFO effective Dec 18, 2024.
- Resignation not due to any disagreement on financial reporting matters.
- CEO Thomas McCourt will serve as interim principal financial officer.
- Company will search for a new CFO; interim arrangement in place.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1446847/000110465924125937/0001104659-24-125937-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1446847/000110465924125937/tm2430282d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-125937

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer